Independent , Honest and Dignified Journalism

WHO Launches New Training Manual to Improve Early Breast Cancer Detection and Treatment

The global health agency urges countries to strengthen screening, diagnosis and coordinated cancer care, aiming to ensure that at least 60 per cent of new breast cancer cases are identified at an early stage.

GENEVA, Oct 19: The World Health Organization (WHO) has released a new training manual to help countries strengthen breast cancer prevention, early detection, diagnosis and treatment, highlighting the importance of building effective healthcare programmes that can identify the disease before it advances.

Announced on Monday, the Global Breast Cancer Initiative (GBCI) Training Manual is designed primarily for programme managers responsible for establishing or improving cancer services at national, regional and healthcare facility levels. The document translates international recommendations into practical steps that governments and health organisations can adapt to their local healthcare systems.

The manual covers the full continuum of breast cancer care, including prevention, early detection, timely diagnosis, treatment planning, access to medical products and technologies, multidisciplinary clinical services and patient navigation. The WHO said the resource is intended to strengthen the capacity of healthcare administrators, medical professionals and implementing partners.

A central objective of the initiative is to ensure that at least 60 per cent of newly diagnosed breast cancer cases are detected at an early stage. The agency emphasised that treatment is generally more effective, better tolerated and less costly when the disease is identified before it progresses.

The launch comes during Breast Cancer Awareness Month, observed internationally in October, when health organisations step up efforts to improve public understanding of the disease and encourage timely medical consultation.

Early diagnosis remains a priority

Breast cancer continues to pose a major public health challenge, particularly in countries where access to diagnostic facilities, trained specialists and comprehensive treatment remains limited.

The WHO’s Global Breast Cancer Initiative, established in 2021, seeks to reduce breast cancer mortality by improving health promotion, early detection, diagnostic services and access to appropriate treatment. Its long-term ambition is to reduce breast cancer mortality by 2.5 per cent annually, potentially saving 2.5 million lives over two decades.

The organisation’s new manual is intended to help governments turn these broad objectives into operational programmes. Rather than offering a single model for every country, it provides a framework that can be adapted to local circumstances, available resources and existing healthcare infrastructure.

This flexibility is important because cancer services differ significantly between countries and even between regions within the same nation. Urban centres may have specialist hospitals, imaging equipment and oncology teams, while rural and underserved communities may face long journeys, financial barriers and delays in receiving diagnostic results.

By providing step-by-step guidance, the manual aims to help programme managers identify gaps in services, organise referral pathways and improve coordination between primary healthcare facilities, diagnostic centres and specialist hospitals.

Strengthening the patient journey

Effective cancer care involves more than identifying a suspicious lump. Patients must be able to move through several stages of the healthcare system without unnecessary delays.

The process may begin with public awareness and recognition of possible symptoms. Individuals who require further assessment must then be able to access clinical examinations and appropriate diagnostic investigations. Where cancer is suspected or confirmed, referral systems should connect patients with specialists who can determine the most suitable treatment.

Delays at any stage can create additional difficulties. Patients may abandon investigations because of travel expenses, uncertainty about where to seek help or difficulty navigating a complex health system.

The WHO manual includes patient navigation as one of its key areas. This approach helps people understand their care pathway, attend appointments, complete investigations and connect with the services they need.

Patient navigation can be especially valuable for individuals who face financial, geographical, language or administrative barriers. Depending on the healthcare system, support may be provided by trained personnel who coordinate appointments, explain referral procedures and help patients remain engaged with treatment.

The manual also highlights multidisciplinary care, which brings together different specialists involved in breast cancer management. Depending on the patient’s condition, this may include surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, nurses and other healthcare professionals.

Coordinated decision-making can help ensure that diagnosis and treatment plans are based on the patient’s clinical needs rather than on the availability of only one type of service.

Building stronger diagnostic and treatment systems

The WHO initiative recognises that early detection must be supported by adequate diagnostic capacity. Public awareness campaigns alone cannot deliver better outcomes if patients are unable to obtain reliable assessments or receive timely treatment after a diagnosis.

Healthcare authorities therefore need to consider the availability of trained personnel, diagnostic equipment, laboratory services, essential medicines and appropriate treatment facilities.

Reliable referral arrangements are equally important. Primary healthcare providers should be able to identify patients who need further evaluation and direct them to suitable facilities. Diagnostic centres and hospitals must then have systems to communicate findings and organise subsequent care.

The manual’s inclusion of health products and technologies reflects the importance of integrating equipment and medical supplies into broader service planning. Procuring technology without providing maintenance, trained operators and sustainable operating budgets may not deliver the expected benefits.

Countries also need to monitor whether patients are progressing through the system in a timely manner. Tracking referrals, diagnostic completion, treatment initiation and follow-up can help administrators identify weaknesses and direct resources towards areas where delays are greatest.

The WHO framework encourages governments to assess existing services before deciding where additional investment is most urgently required.

International interest in adapting the guidance

The WHO said several countries had already expressed interest in using the new manual following its release. The Global Breast Cancer Initiative is working with partners in Ethiopia, Eswatini and the Philippines to adapt the training materials to local contexts and integrate them into existing national training programmes.

These efforts reflect the need to tailor international guidance to different healthcare structures. A country with established cancer centres may focus on improving referral coordination and reducing waiting times, while another may prioritise training, diagnostic capacity and access to specialist services outside major cities.

Adapting the materials to local conditions can also help governments align cancer programmes with existing public health priorities and workforce capabilities.

The WHO’s wider initiative encourages countries to strengthen three interconnected areas: health promotion and early detection, timely diagnosis, and comprehensive breast cancer management. Progress in one area must be accompanied by improvements in the others if patients are to benefit from earlier identification of the disease.

Awareness and timely medical consultation

Public awareness remains an important part of breast cancer control. People should be informed about potential warning signs and encouraged to seek professional advice when they notice unusual changes.

Possible symptoms can include a new breast lump, changes in breast shape or size, nipple changes, unusual discharge or alterations in the skin. Such changes do not automatically indicate cancer, but they warrant appropriate medical assessment.

Screening recommendations vary according to age, individual risk and national health guidance. People should consult qualified healthcare professionals about suitable screening and diagnostic options rather than relying solely on self-examination or online information.

Health systems must also communicate clearly with patients so that awareness campaigns lead to practical access to services. Encouraging someone to seek care is only the first step; appointments, diagnostic investigations and appropriate treatment must be available when needed.

The WHO’s latest manual provides programme managers with a structured resource for improving these connections. Its impact will depend on how effectively countries incorporate the recommendations into national strategies, train healthcare teams and sustain investment in cancer services.

By focusing on early detection and coordinated treatment, the initiative seeks to reduce avoidable delays and improve the chances that people diagnosed with breast cancer can receive timely, appropriate care.

WhatsApp Channel